Clinical Medicine
Listando 71 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions
19
Twitter
0
Wikipedia
53
News
0
Policy
Article
Ibrutinib for patients with rituximab-refractory Waldenstrm's macro globulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
Dimopoulos, Meletios A.; Trotman, Judith; Tedeschi, Alessandra; Matous, Jeff Rey V.; Macdonald, David; Tam, Constantine; Tournilhac, Olivier; Ma, Shuo; Oriol, Albert; Heffner, Leonard T.; Shustik, Chaim; Garcia-Sanz, Ramon; Cornell, Robert F.; de Larrea, C
LANCET ONCOLOGY
1470-2045 (2017)
DOI /
10.1016/s1470-2045(16)30632-5
Mentions
37
Twitter
0
Wikipedia
22
News
0
Policy
Article
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma
Richardson, Paul G.; Oriol, Albert; Larocca, Alessandra; Blade, Joan; Cavo, Michele; Rodriguez-Otero, Paula; Leleu, Xavier; Nadeem, Omar; Hiemenz, John W.; Hassoun, Hani; Touzeau, Cyrille; Alegre, Adrian; Paner, Agne; Maisel, Christopher; Mazumder, Amitabh
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2021)
DOI /
10.1200/jco.20.02259
Green published, Gold other
Mentions
60
Twitter
2
Wikipedia
15
News
3
Policy
Article
Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial
Dimopoulos, Meletios A.; Goldschmidt, Hartmut; Niesvizky, Ruben; Joshua, Douglas; Chng, Wee-Joo; Oriol, Albert; Orlowski, Robert Z.; Ludwig, Heinz; Facon, Thierry; Hajek, Roman; Weisel, Katja; Hungria, Vania; Minuk, Leonard; Feng, Shibao; Zahlten-Kumeli, A
LANCET ONCOLOGY
1470-2045 (2017)
DOI /
10.1016/s1470-2045(17)30578-8
Mentions
128
Twitter
0
Wikipedia
4
News
0
Policy
Article
Teclistamab, a B-cell maturation antigenxCD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
Usmani, Saad Z.; Garfall, Alfred L.; van de Donk, Niels W. C. J.; Nahi, Hareth; San-Miguel, Jesus F.; Oriol, Albert; Rosinol, Laura; Chari, Ajai; Bhutani, Manisha; Karlin, Lionel; Benboubker, Lotfi; Pei, Lixia; Verona, Raluca; Girgis, Suzette; Stephenson,
LANCET
0140-6736 (2021)
DOI /
10.1016/s0140-6736(21)01338-6
Mentions
76
Twitter
0
Wikipedia
9
News
2
Policy
Article
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
Richardson, Paul G.; Oriol, Albert; Beksac, Meral; Liberati, Anna Marina; Galli, Monica; Schjesvold, Fredrik; Lindsay, Jindriska; Weisel, Katja; White, Darrell; Facon, Thierry; Miguel, Jesus Son; Sunami, Kazutaka; O'Gorman, Peter; Sonneveld, Pieter; Robak,
LANCET ONCOLOGY
1470-2045 (2019)
DOI /
10.1016/s1470-2045(19)30152-4
Mentions
82
Twitter
0
Wikipedia
4
News
0
Policy
Article
Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma
Chari, Ajai; Martinez-Lopez, Joaquin; Mateos, Maria-Victoria; Blade, Joan; Benboubker, Lotfi; Oriol, Albert; Arnulf, Bertrand; Rodriguez-Otero, Paula; Pineiro, Luis; Jakubowiak, Andrzej; De Boer, Carla; Wang, Jianping; Clemens, Pamela L.; Ukropec, Jon; Sch
BLOOD
0006-4971 (2019)
DOI /
10.1182/blood.2019000722
Green published
Mentions
124
Twitter
0
Wikipedia
0
News
0
Policy
Article
Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma
Usmani, Saad Z.; Nahi, Hareth; Mateos, Maria-Victoria; van de Donk, Niels W. C. J.; Chari, Ajai; Kaufman, Jonathan L.; Moreau, Philippe; Oriol, Albert; Plesner, Torben; Benboubker, Lotfi; Hellemans, Peter; Masterson, Tara; Clemens, Pamela L.; Luo, Man; Liu
BLOOD
0006-4971 (2019)
DOI /
10.1182/blood.2019000667
Green published, Bronze
Mentions
115
Twitter
0
Wikipedia
0
News
0
Policy
Article
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
Usmani, Saad Zafar; Schjesvold, Fredrik; Oriol, Albert; Karlin, Lionel; Cavo, Michele; Rifkin, Robert M.; Yimer, Habte Aragaw; Leblanc, Richard; Takezako, Naoki; McCroskey, Robert Donald; Lim, Andrew Boon Ming; Suzuki, Kenshi; Kosugi, Hiroshi; Grigoriadis,
LANCET HAEMATOLOGY
2352-3026 (2019)
DOI /
10.1016/s2352-3026(19)30109-7
Bronze, Green accepted
Mentions
65
Twitter
0
Wikipedia
5
News
2
Policy
Article
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
Moreau, Philippe; Dimopoulos, Meletios-Athanasios; Mikhael, Joseph; Yong, Kwee; Capra, Marcelo; Facon, Thierry; Hajek, Roman; Spicka, Ivan; Baker, Ross; Kim, KiHyun; Martinez, Gracia; Min, Chang-Ki; Pour, Ludek; Leleu, Xavier; Oriol, Albert; Koh, Youngil;
LANCET
0140-6736 (2021)
DOI /
10.1016/s0140-6736(21)00592-4
Mentions
61
Twitter
0
Wikipedia
2
News
0
Policy
Article
Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma
Paiva, Bruno; Puig, Noemi; Cedena, Maria-Teresa; Rosinol, Laura; Cordon, Lourdes; Vidriales, Maria-Belen; Burgos, Leire; Flores-Montero, Juan; Sanoja-Flores, Luzalba; Lopez-Anglada, Lucia; Maldonado, Roberto; de la Cruz, Javier; Gutierrez, Norma C.; Calasa
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2020)
DOI /
10.1200/jco.19.01231
Green published
Mentions
52
Twitter
0
Wikipedia
3
News
0
Policy
Article
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial
Dimopoulos, Meletios A.; Spicka, Ivan; Quach, Hang; Oriol, Albert; Hajek, Roman; Garg, Mamta; Beksac, Meral; Bringhen, Sara; Katodritou, Eirini; Chng, Wee-Joo; Leleu, Xavier; Iida, Shinsuke; Mateos, Maria-Victoria; Morgan, Gareth; Vorog, Alexander; Labotka
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2020)
DOI /
10.1200/jco.20.02060
Gold other, Green published
Mentions
69
Twitter
0
Wikipedia
2
News
1
Policy
Article
Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials
Lahuerta, Juan-Jose; Paiva, Bruno; Vidriales, Maria-Belen; Cordon, Lourdes; Cedena, Maria-Teresa; Puig, Noemi; Martinez-Lopez, Joaquin; Rosinol, Laura; Gutierrez, Norma C.; Martin-Ramos, Maria-Luisa; Oriol, Albert; Teruel, Ana-Isabel; Echeveste, Maria-Asun
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2017)
DOI /
10.1200/jco.2016.69.2517
Green accepted
Mentions
19
Twitter
0
Wikipedia
1
News
0
Policy
Article
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma
Goicoechea, Ibai; Puig, Noemi; Cedena, Maria-Teresa; Burgos, Leire; Cordon, Lourdes; Vidriales, Maria-Belen; Flores-Montero, Juan; Gutierrez, Norma; Calasanz, Maria-Jose; Martin Ramos, Maria-Luisa; Lara-Astiaso, David; Vilas-Zornoza, Amaia; Alignani, Diego
BLOOD
0006-4971 (2021)
DOI /
10.1182/blood.2020006731
Mentions
41
Twitter
0
Wikipedia
1
News
0
Policy
Article
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial
Puig, Noemi; Hernandez, Miguel T.; Rosinol, Laura; Gonzalez, Esther; de Arriba, Felipe; Oriol, Albert; Gonzalez-Calle, Veronica; Escalante, Fernando; de la Rubia, Javier; Gironella, Mercedes; Rios, Rafael; Garcia-Sanchez, Ricarda; Arguinano, Jose M.; Alegr
BLOOD CANCER JOURNAL
2044-5385 (2021)
DOI /
10.1038/s41408-021-00490-8
Gold DOAJ, Green published
Mentions
25
Twitter
0
Wikipedia
1
News
0
Policy
Article
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma
Rosinol, Laura; Oriol, Albert; Rios, Rafael; Sureda, Anna; Jesus Blanchard, Maria; Teodoro Hernandez, Miguel; Martinez-Martinez, Rafael; Moraleda, Jose M.; Jarque, Isidro; Bargay, Juan; Gironella, Mercedes; de Arriba, Felipe; Palomera, Luis; Gonzalez-Monte
BLOOD
0006-4971 (2019)
DOI /
10.1182/blood.2019000241
Bronze, Green published
Mentions
32
Twitter
0
Wikipedia
0
News
0
Policy
Article
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
Mateos, Maria-Victoria; Blacklock, Hilary; Schjesvold, Fredrik; Oriol, Albert; Simpson, David; George, Anupkumar; Goldschmidt, Hartmut; Larocca, Alessandra; Chanan-Khan, Asher; Sherbenou, Daniel; Avivi, Irit; Benyamini, Noam; Iida, Shinsuke; Matsumoto, Mor
LANCET HAEMATOLOGY
2352-3026 (2019)
DOI /
10.1016/s2352-3026(19)30110-3
Green accepted
Mentions
11
Twitter
0
Wikipedia
4
News
2
Policy
Article
Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR
Chng, W-J; Goldschmidt, H.; Dimopoulos, M. A.; Moreau, P.; Joshua, D.; Palumbo, A.; Facon, T.; Ludwig, H.; Pour, L.; Niesvizky, R.; Oriol, A.; Rosinol, L.; Suvorov, A.; Gaidano, G.; Pika, T.; Weisel, K.; Goranova-Marinova, V.; Gillenwater, H. H.; Mohamed,
LEUKEMIA
0887-6924 (2017)
DOI /
10.1038/leu.2016.390
Gold other, Green published
Mentions
5
Twitter
0
Wikipedia
3
News
0
Policy
Article
Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low-Dose Dexamethasone in the Treatment of Multiple Myeloma: A Matching Adjusted Indirect Comparison
Van Sanden, Suzy; Ito, Tetsuro; Diels, Joris; Vogel, Martin; Belch, Andrew; Oriol, Albert
ONCOLOGIST
1083-7159 (2018)
DOI /
10.1634/theoncologist.2017-0103
Green published, Bronze
Mentions
4
Twitter
0
Wikipedia
3
News
0
Policy
Article
Bortezomib and thalidomide maintenance after stem cell transplantation for multiple myeloma: a PETHEMA/GEM trial
Rosinol, L.; Oriol, A.; Teruel, A. I.; de la Guia, A. L.; Blanchard, Ma J.; de la Rubia, J.; Granell, M.; Sampol, Ma A.; Palomera, L.; Gonzalez, Y.; Etxebeste, Ma A.; Martinez-Martinez, R.; Hernandez, M. T.; de Arriba, F.; Alegre, A.; Cibeira, Ma T.; Mateo
LEUKEMIA
0887-6924 (2017)
DOI /
10.1038/leu.2017.35
Mentions
36
Twitter
0
Wikipedia
0
News
0
Policy
Article
Role of urine immunofixation in the complete response assessment of MM patients other than light-chain-only disease
Lahuerta, Juan-Jose; Jimenez-Ubieto, Ana; Paiva, Bruno; Martinez-Lopez, Joaquin; Gonzalez-Medina, Jose; Lopez-Anglada, Lucia; Cedena, Maria-Teresa; Puig, Noemi; Oriol, Albert; Blanchard, Maria-Jesus; Rios, Rafael; Martin, Jesus; Martinez, Rafael; Sureda, A
BLOOD
0006-4971 (2019)
DOI /
10.1182/blood.2019000671
Bronze
Mentions
13
Twitter
0
Wikipedia
1
News
0
Policy
Article
Carfilzomib-lenalidomide-dexamethasone vs lenalidomide-dexamethasone in relapsed multiple myeloma by previous treatment
Dimopoulos, M. A.; Stewart, A. K.; Masszi, T.; Spicka, I.; Oriol, A.; Hajek, R.; Rosinol, L.; Siegel, D.; Mihaylov, G. G.; Goranova-Marinova, V.; Rajnics, P.; Suvorov, A.; Niesvizky, R.; Jakubowiak, A.; San-Miguel, J.; Ludwig, H.; Ro, S.; Aggarwal, S.; Mor
BLOOD CANCER JOURNAL
2044-5385 (2017)
DOI /
10.1038/bcj.2017.31
Gold DOAJ, Green published
Mentions
5
Twitter
0
Wikipedia
4
News
2
Policy
Article
Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study
Moreau, P.; Joshua, D.; Chng, W-J; Palumbo, A.; Goldschmidt, H.; Hajek, R.; Facon, T.; Ludwig, H.; Pour, L.; Niesvizky, R.; Oriol, A.; Rosinol, L.; Suvorov, A.; Gaidano, G.; Pika, T.; Weisel, K.; Goranova-Marinova, V.; Gillenwater, H. H.; Mohamed, N.; Agga
LEUKEMIA
0887-6924 (2017)
DOI /
10.1038/leu.2016.186
Gold other, Green published
Mentions
11
Twitter
0
Wikipedia
1
News
0
Policy
Article
Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature
Rodriguez-Otero, Paula; Victoria Mateos, Maria; Martinez-Lopez, Joaquin; Hernandez, Miguel-Teodoro; Ocio, Enrique M.; Rosinol, Laura; Martinez, Rafael; Teruel, Ana-Isabel; Gutierrez, Norma C.; Bargay, Joan; Bengoechea, Enrique; Gonzalez, Yolanda; Perez de
BLOOD CANCER JOURNAL
2044-5385 (2019)
DOI /
10.1038/s41408-019-0176-x
Gold DOAJ, Green published
Mentions
10
Twitter
0
Wikipedia
2
News
0
Policy
Article
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)
Hajek, R.; Masszi, T.; Petrucci, M. T.; Palumbo, A.; Rosinol, L.; Nagler, A.; Yong, K. L.; Oriol, A.; Minarik, J.; Pour, L.; Dimopoulos, M. A.; Maisnar, V.; Rossi, D.; Kasparu, H.; Van Droogenbroeck, J.; Yehuda, D. B.; Hardan, I.; Jenner, M.; Calbecka, M.;
LEUKEMIA
0887-6924 (2017)
DOI /
10.1038/leu.2016.176
Green published, Gold other
Mentions
8
Twitter
0
Wikipedia
1
News
0
Policy
Article
Differentiation stage of myeloma plasma cells: biological and clinical significance
Paiva, B.; Puig, N.; Cedena, M. T.; de Jong, B. G.; Ruiz, Y.; Rapado, I.; Martinez-Lopez, J.; Cordon, L.; Alignani, D.; Delgado, J. A.; van Zelm, M. C.; van Dongen, J. J. M.; Pascual, M.; Agirre, X.; Prosper, F.; Martin-Subero, J. I.; Vidriales, M-B; Gutie
LEUKEMIA
0887-6924 (2017)
DOI /
10.1038/leu.2016.211
Green accepted
Mentions
20
Twitter
0
Wikipedia
0
News
0
Policy
Article
Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma
Granell, Miquel; Senin, Alicia; Barata, Anna; Cibeira, Maria-Teresa; Gironella, Mercedes; Lopez-Pardo, Jordi; Motllo, Cristina; Garcia-Guinon, Antoni; Ben-Azaiz, Randa; Abella, Eugenia; Soler, Alfons; Canet, Marta; Ma Marti, Josep; Martino, Rodrigo; Sierra
BONE MARROW TRANSPLANTATION
0268-3369 (2021)
DOI /
10.1038/s41409-021-01429-0
Mentions
2
Twitter
0
Wikipedia
1
News
0
Policy
Article
Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and Subgroups
Orlowski, Robert Z.; Moreau, Philippe; Niesvizky, Ruben; Ludwig, Heinz; Oriol, Albert; Chng, Wee Joo; Goldschmidt, Hartmut; Yang, Zhao; Kimball, Amy S.; Dimopoulos, Meletios
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
2152-2650 (2019)
DOI /
10.1016/j.clml.2019.04.018
Gold other
Mentions
8
Twitter
0
Wikipedia
0
News
2
Policy
Article
Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma
Brighton, Timothy A.; Khot, Amit; Harrison, Simon J.; Ghez, David; Weiss, Brendan M.; Kirsch, Andres; Magen, Hila; Gironella, Mercedes; Oriol, Albert; Streetly, Matthew; Kranenburg, Britte; Qin, Xiang; Bandekar, Rajesh; Hu, Peter; Guilfoyle, Mary; Qi, Ming
CLINICAL CANCER RESEARCH
1078-0432 (2019)
DOI /
10.1158/1078-0432.ccr-18-3470
Bronze
Mentions
14
Twitter
0
Wikipedia
0
News
0
Policy
Article
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
Medina, Alejandro; Puig, Noemi; Flores-Montero, Juan; Jimenez, Cristina; Sarasquete, M. -Eugenia; Garcia-Alvarez, Maria; Prieto-Conde, Isabel; Chillon, Carmen; Alcoceba, Miguel; Gutierrez, Norma C.; Oriol, Albert; Rosinol, Laura; Blade, Joan; Gironella, Me
BLOOD CANCER JOURNAL
2044-5385 (2020)
DOI /
10.1038/s41408-020-00377-0
Green published, Gold
Mentions
16
Twitter
0
Wikipedia
0
News
0
Policy
Article
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
Alameda, Daniel; Goicoechea, Ibai; Vicari, Marco; Arriazu, Elena; Nevone, Alice; Rodriguez, Sara; Lasa, Marta; Puig, Noemi; Teresa Cedena, Maria; Alignani, Diego; Garate, Sonia; Lara-Astiaso, David; Vilas-Zornoza, Amaia; Sarvide, Sarai; Ocio, Enrique M.; L
BLOOD
(2021)
DOI /
10.1182/blood.2020009754
Mentions
6
Twitter
0
Wikipedia
2
News
0
Policy
Article
Health-related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial
Plesner, Torben; Dimopoulos, Meletios A.; Oriol, Albert; San-Miguel, Jesus; Bahlis, Nizar J.; Rabin, Neil; Suzuki, Kenshi; Yoon, Sung-Soo; Ben-Yehuda, Dina; Cook, Gordon; Goldschmidt, Hartmut; Grosicki, Sebastian; Qin, Xiang; Fastenau, John; Garvin, Wendy;
BRITISH JOURNAL OF HAEMATOLOGY
0007-1048 (2021)
DOI /
10.1111/bjh.17435
Mentions
15
Twitter
0
Wikipedia
0
News
0
Policy
Article
Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trials
Arana, P.; Paiva, B.; Cedena, M-T; Puig, N.; Cordon, L.; Vidriales, M-B; Gutierrez, N. C.; Chiodi, F.; Burgos, L.; Anglada, L-L; Martinez-Lopez, J.; Hernandez, M-T; Teruel, A-I; Gironella, M.; Echeveste, M-A; Rosinol, L.; Martinez, R.; Oriol, A.; de la Rub
LEUKEMIA
0887-6924 (2018)
DOI /
10.1038/leu.2017.320
Mentions
11
Twitter
0
Wikipedia
0
News
0
Policy
Article
Biological and clinical signi fi cance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma
Maia, Catarina; Puig, Noemi; Cedena, Maria-Teresa; Goicoechea, Ibai; Valdes-Mas, Rafael; Vazquez, Iria; Chillon, Maria-Carmen; Aguirre, Paula; Sarvide, Sarai; Gracia-Aznarez, Francisco Javier; Alkorta, Gorka; Calasanz, Maria-Jose; Garcia-Sanz, Ramon; Gonza
BLOOD
0006-4971 (2020)
DOI /
10.1182/blood.2019003382
Mentions
3
Twitter
0
Wikipedia
1
News
0
Policy
Article
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma
Perez, Cristina; Botta, Cirino; Zabaleta, Aintzane; Puig, Noemi; Cedena, Maria-Teresa; Goicoechea, Ibai; Alameda, Daniel; San Jose-Eneriz, Edurne; Merino, Juana; Rodriguez-Otero, Paula; Maia, Catarina; Alignani, Diego; Maiso, Patricia; Manrique, Irene; Lar
BLOOD
0006-4971 (2020)
DOI /
10.1182/blood.2019004537
Mentions
3
Twitter
0
Wikipedia
0
News
2
Policy
Article
Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial
Magnano, Laura; Montoto, Silvia; Gonzalez-Barca, Eva; Briones, Javier; Manuel Sancho, Juan; Muntanola, Ana; Salar, Antonio; Besalduch, Joan; Escoda, Lourdes; Moreno, Carol; Domingo-Domenech, Eva; Estany, Cristina; Oriol, Albert; Altes, Albert; Pedro, Carme
ANNALS OF HEMATOLOGY
0939-5555 (2017)
DOI /
10.1007/s00277-017-2920-2
Mentions
9
Twitter
0
Wikipedia
0
News
0
Policy
Article
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients
Medina, Alejandro; Jimenez, Cristina; Eugenia Sarasquete, M.; Gonzalez, Marcos; Carmen Chillon, M.; Balanzategui, Ana; Prieto-Conde, Isabel; Garcia-Alvarez, Maria; Puig, Noemi; Gonzalez-Calle, Veronica; Alcoceba, Miguel; Cuenca, Isabel; Barrio, Santiago; E
BLOOD CANCER JOURNAL
2044-5385 (2020)
DOI /
10.1038/s41408-020-0283-8
Gold DOAJ, Green published
Mentions
6
Twitter
0
Wikipedia
0
News
2
Policy
Article
Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study
Dimopoulos, Meletios A.; Stewart, A. Keith; Masszi, Tamas; Spicka, Ivan; Oriol, Albert; Hajek, Roman; Rosinol, Laura; Siegel, David; Mihaylov, Georgi G.; Goranova-Marinova, Vesselina; Rajnics, Peter; Suvorov, Aleksandr; Niesvizky, Ruben; Jakubowiak, Andrze
BRITISH JOURNAL OF HAEMATOLOGY
0007-1048 (2017)
DOI /
10.1111/bjh.14549
Gold other, Green published
Mentions
10
Twitter
0
Wikipedia
0
News
0
Policy
Letter
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
Ruiz-Heredia, Yanira; Sanchez-Vega, Beatriz; Onecha, Esther; Barrio, Santiago; Alonso, Rafael; Carlos Martinez-Avila, Jose; Cuenca, Isabel; Agirre, Xabier; Braggio, Esteban; Hernandez, Miguel-T.; Martinez, Rafael; Rosinol, Laura; Gutierrez, Norma; Martin-R
HAEMATOLOGICA
0390-6078 (2018)
DOI /
10.3324/haematol.2018.188839
Gold DOAJ, Green published
Mentions
9
Twitter
0
Wikipedia
0
News
0
Policy
Article
A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
Hajek, Roman; Pour, Ludek; Ozcan, Muhit; Sanchez, Jesus Martin; Sanz, Ramon Garcia; Anagnostopoulos, Achilles; Oriol, Albert; Cascavilla, Nicola; Terjung, Andreas; Lee, Yihua; Briso, Eva M.; Dobkowska, Edyta; Hauns, Bernhard; Spicka, Ivan
EUROPEAN JOURNAL OF HAEMATOLOGY
0902-4441 (2020)
DOI /
10.1111/ejh.13377
Green published, Gold other
Mentions
16
Twitter
0
Wikipedia
0
News
0
Policy
Article
Single-Agent Ibrutinib for Rituximab-Refractory Waldenstrom Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate (TM) Trial
Trotman, Judith; Buske, Christian; Tedeschi, Alessandra; Matous, Jeffrey V.; Macdonald, David; Tam, Constantine S.; Tournilhac, Olivier; Ma, Shuo; Treon, Steven P.; Oriol, Albert; Ping, Jerry; Briso, Eva M.; Arango-Hisijara, Israel; Dimopoulos, Meletios A.
CLINICAL CANCER RESEARCH
1078-0432 (2021)
DOI /
10.1158/1078-0432.ccr-21-1497
Green published
Mentions
8
Twitter
0
Wikipedia
0
News
0
Policy
Article
Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis
Puig, Noemi; Paiva, Bruno; Lasa, Marta; Burgos, Leire; Perez, Jose J.; Merino, Juana; Moreno, Cristina; Vidriales, Maria-Belen; Gomez Toboso, Dolores; Cedena, Maria-Teresa; Ocio, Enrique M.; Lecumberri, Ramon; Garcia de Coca, Alfonso; Labrador, Jorge; Gonz
LEUKEMIA
0887-6924 (2019)
DOI /
10.1038/s41375-018-0308-5
Mentions
9
Twitter
0
Wikipedia
0
News
0
Policy
Article
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis
Cuenca, Isabel; Alameda, Daniel; Sanchez-Vega, Beatriz; Gomez-Sanchez, David; Alignani, Diego; Lasa, Marta; Onecha, Esther; Lecumberri, Ramon; Prosper, Felipe; Ocio, Enrique M.; Gonzalez, Maria Esther; de Coca, Alfonso; de la Rubia, Javier; Gironella, Merc
LEUKEMIA
0887-6924 (2020)
DOI /
10.1038/s41375-020-0800-6
Green published, Gold other
Mentions
11
Twitter
0
Wikipedia
0
News
0
Policy
Article
Dose intensity and treatment duration of bortezomib in transplant-ineligible newly diagnosed multiple myeloma
Ibarra, Gladys; Pena, Marta; Abril, Laura; Senin, Alicia; Maluquer, Clara; Clapes, Victoria; Baca, Cristina; Bustamante, Gabriela; Sureda, Anna; Oriol, Albert
EUROPEAN JOURNAL OF HAEMATOLOGY
0902-4441 (2021)
DOI /
10.1111/ejh.13643
Mentions
6
Twitter
0
Wikipedia
0
News
0
Policy
Article
Impact of response to treatment in health-related quality of life patient-reported outcomes in elderly patients with relapsed multiple myeloma
Oriol, Albert; Ibarra, Gladys; Abella, Eugenia; Motllo, Cristina; Cibeira, Maria-Teresa; Garcia, Antoni; Escoda, Lourdes; Granell, Miquel; Ben-Azaiz, Randa; Cervera, Marta; Cabezudo, Elena; Fernandez, Carlos; Rosinol, Laura
LEUKEMIA & LYMPHOMA
1042-8194 (2020)
DOI /
10.1080/10428194.2020.1817439
Mentions
7
Twitter
0
Wikipedia
0
News
0
Policy
Article
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study
Larocca, Alessandra; Leleu, Xavier; Touzeau, Cyrille; Blade, Joan; Paner, Agne; Mateos, Maria-Victoria; Cavo, Michele; Maisel, Christopher; Alegre, Adrian; Oriol, Albert; Raptis, Anastasios; Rodriguez-Otero, Paula; Mazumder, Amitabha; Laubach, Jacob; Nadee
BRITISH JOURNAL OF HAEMATOLOGY
0007-1048 (2021)
DOI /
10.1111/bjh.17887
Hybrid
Mentions
10
Twitter
0
Wikipedia
0
News
0
Policy
Letter
Decitabine improves response rate and prolongs progression-free survival in older patients with newly diagnosed acute myeloid leukemia and with monosomal karyotype: A subgroup analysis of the DACO-016 trial
Wierzbowska, Agnieszka; Wawrzyniak, Ewa; Pluta, Agnieszka; Robak, Tadeusz; Mazur, Grzegorz J.; Dmoszynska, Anna; Cermak, Jaroslav; Oriol, Albert; Lysak, Daniel; Arthur, Chris; Doyle, Margaret; Xiu, Liang; Ravandi, Farhad; Kantarjian, Hagop M.
AMERICAN JOURNAL OF HEMATOLOGY
0361-8609 (2018)
DOI /
10.1002/ajh.25062
Bronze
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Review
Current and Novel Alkylators in Multiple Myeloma
Schjesvold, Fredrik; Oriol, Albert
CANCERS
(2021)
DOI /
10.3390/cancers13102465
Gold DOAJ, Green published
Mentions
5
Twitter
0
Wikipedia
0
News
0
Policy
Article
Efficacy and safety of weekly carfilzomib (70 mg/m(2)), dexamethasone, and daratumumab (KdD70) is comparable to twice-weekly KdD56 while being a more convenient dosing option: a cross-study comparison of the CANDOR and EQUULEUS studies
Leleu, Xavier; Beksac, Meral; Chou, Takaaki; Dimopoulos, Meletios; Yoon, Sung-Soo; Prince, H. Miles; Pour, Ludek; Shelekhova, Tatiana; Chari, Ajai; Khurana, Monica; Zhang, Jianqi; Obreja, Mihaela; Qi, Ming; Oriol, Albert; Siegel, David
LEUKEMIA & LYMPHOMA
1042-8194 (2020)
DOI /
10.1080/10428194.2020.1832672
Hybrid
Mentions
7
Twitter
0
Wikipedia
0
News
0
Policy
Article
Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma part 2 of the open-label, multicenter, dose-escalation phase Ib study (PAVO)
San-Miguel, Jesus; Usmani, Saad Z.; Mateos, Maria-Victoria; van de Donk, Niels W. C. J.; Kaufman, Jonathan L.; Moreau, Philippe; Oriol, Albert; Plesner, Torben; Benboubker, Lotfi; Liu, Kevin; Hellemans, Peter; Masterson, Tara; Clemens, Pamela L.; Luo, Man;
HAEMATOLOGICA
0390-6078 (2021)
DOI /
10.3324/haematol.2019.243790
Gold DOAJ, Green published
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma
Misiewicz-Krzeminska, Irena; de Ramon, Cristina; Corchete, Luis A.; Krzeminski, Patryk; Rojas, Elizabeta A.; Isidro, Isabel; Garcia-Sanz, Ramon; Martinez-Lopez, Joaquin; Oriol, Albert; Blade, Joan; Lahuerta, Juan-Jose; San Miguel, Jesus; Rosinol, Laura; Ma
BLOOD ADVANCES
2473-9529 (2020)
DOI /
10.1182/bloodadvances.2020002711
Bronze, Green published
Mentions
5
Twitter
0
Wikipedia
0
News
0
Policy
Article
Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma
Raje, Noopur S.; Moreau, Philippe; Terpos, Evangelos; Benboubker, Lotfi; Grzasko, Norbert; Holstein, Sarah A.; Oriol, Albert; Huang, Shang-Yi; Beksac, Meral; Kuliczkowski, Kazimierz; Tai, Datchen F.; Wooldridge, James E.; Conti, Ilaria; Kaiser, Christopher
BRITISH JOURNAL OF HAEMATOLOGY
0007-1048 (2017)
DOI /
10.1111/bjh.14483
Bronze
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: biological and clinical utility
Misiewicz-Krzeminska, Irena; Antonio Corchete, Luis; Rojas, Elizabeta A.; Martinez-Lopez, Joaquin; Garcia-Sanz, Ramon; Oriol, Albert; Blade, Joan; Lahuerta, Juan-Jose; San Miguel, Jesus; Mateos, Maria-Victoria; Gutierrez, Norma C.
HAEMATOLOGICA
0390-6078 (2018)
DOI /
10.3324/haematol.2017.181628
Gold DOAJ, Green published
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array
Garcia-Sanz, Ramon; Antonio Corchete, Luis; Alcoceba, Miguel; Carmen Chillon, Maria; Jimenez, Cristina; Prieto, Isabel; Garcia-Alvarez, Maria; Puig, Noemi; Rapado, Immaculada; Barrio, Santiago; Oriol, Albert; Jesus Blanchard, Maria; de la Rubia, Javier; Ma
HEMATOLOGICAL ONCOLOGY
0278-0232 (2017)
DOI /
10.1002/hon.2337
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Article
Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1-acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group
Ocio, Enrique M.; Motllo, Cristina; Rodriguez-Otero, Paula; Martinez-Lopez, Joaquin; Jose Cejalvo, Ma; Martin-Sanchez, Jesus; Blad, Joan; Dolores Garcia-Malo, Ma; Victoria Dourdil, Ma; Garcia-Mateo, Aranzazu; de Arriba, Felipe; Garcia-Sanz, Ramon; de la Ru
BRITISH JOURNAL OF HAEMATOLOGY
0007-1048 (2020)
DOI /
10.1111/bjh.16788
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Review
A critical evaluation of pembrolizumab in addition to lenalidomide and dexamethasone for the treatment of multiple myeloma
Oriol, Albert
EXPERT REVIEW OF HEMATOLOGY
1747-4086 (2020)
DOI /
10.1080/17474086.2020.1744432
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Article
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials
Lopez-Anglada, Lucia; Cueto-Felgueroso, Cecilia; Rosinol, Laura; Oriol, Albert; Isabel Teruel, Ana; Lopez de la Guia, Ana; Bengoechea, Enrique; Palomera, Luis; de Arriba, Felipe; Mariano Hernandez, Jose; Granell, Miquel; Javier Penalver, Francisco; Garcia-
PLOS ONE
1932-6203 (2018)
DOI /
10.1371/journal.pone.0203392
Gold DOAJ, Green published
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?
Jimenez-Ubieto, Ana; Paiva, Bruno; Puig, Noemi; Cedena, Maria-Teresa; Martinez-Lopez, Joaquin; Oriol, Albert; Blanchard, Maria-Jesus; Rios, Rafael; Martin, Jesus; Martinez, Rafael; Sureda, Anna; Hernandez, Miguel-Teodoro; de la Rubia, Javier; Krnisk, Isabe
BLOOD
0006-4971 (2021)
DOI /
10.1182/blood.2021012319
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Review
Limited treatment options in refractory multiple myeloma: promising therapeutic developments
Oriol, Albert; Abril, Laura; Ibarra, Gladys; Senin, Alicia
EXPERT REVIEW OF ANTICANCER THERAPY
1473-7140 (2020)
DOI /
10.1080/14737140.2020.1708721
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Carfilzomib and dexamethasone versus eight cycles of bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma: an indirect comparison using data from the phase 3 ENDEAVOR and CASTOR trials
Weisel, Katja; Majer, Istvan; DeCosta, Lucy; Oriol, Albert; Goldschmidt, Hartmut; Ludwig, Heinz; Campioni, Marco; Szabo, Zsolt; Dimopoulos, Meletios
LEUKEMIA & LYMPHOMA
1042-8194 (2019)
DOI /
10.1080/10428194.2019.1648806
Gold other, Green published
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis
Moreau, Philippe; Dimopoulos, Meletios A.; Richardson, Paul G.; Siegel, David S.; Cavo, Michele; Corradini, Paolo; Weisel, Katja; Delforge, Michel; O'Gorman, Peter; Song, Kevin; Chen, Christine; Bahlis, Nizar; Oriol, Albert; Hansson, Markus; Kaiser, Martin
EUROPEAN JOURNAL OF HAEMATOLOGY
0902-4441 (2017)
DOI /
10.1111/ejh.12903
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Article
Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role
Rodriguez-Otero, Paula; Victoria Mateos, Maria; Martinez-Lopez, Joaquin; Martin-Calvo, Nerea; Hernandez, Miguel-Teodoro; Ocio, Enrique M.; Rosinol, Laura; Martinez, Rafael; Teruel, Ana-Isabel; Gutierrez, Norma C.; Bargay, Joan; Bengoechea, Enrique; Gonzale
LEUKEMIA
0887-6924 (2018)
DOI /
10.1038/s41375-018-0072-6
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Impact of induction treatment before autologous stem cell transplantation on long-term outcome in patients with newly diagnosed multiple myeloma
Gassiot, Susanna; Motllo, Cristina; Llombart, Inuska; Morgades, Mireia; Gonzalez, Yolanda; Garcia-Caro, Montse; Ribera, Josep-Maria; Oriol, Albert
EUROPEAN JOURNAL OF HAEMATOLOGY
0902-4441 (2017)
DOI /
10.1111/ejh.12869
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial
Puig, Noemi; Corchete-Sanchez, Luis A.; Perez-Moran, Jose J.; Davila, Julio; Paino, Teresa; de la Rubia, Javier; Oriol, Albert; Martin-Sanchez, Jesus; de Arriba, Felipe; Blad, Joan; Blanchard, Maria-Jesus; Gonzalez-Calle, Veronica; Garcia-Sanz, Ramon; Paiv
CANCERS
(2020)
DOI /
10.3390/cancers12123615
Gold DOAJ, Green published
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Daratumumab With Cetrelimab, an Anti-PD-1 Monoclonal Antibody, in Relapsed/Refractory Multiple Myeloma
Cohen, Yael C.; Oriol, Albert; Wu, Ka Lung; Lavi, Noa; Vlummens, Philip; Jackson, Carolyn; Garvin, Wendy; Carson, Robin; Crist, Wendy; Fu, Jiayu; Feng, Huaibao; Xie, Hong; Schecter, Jordan; San-Miguel, Jesus; Lonial, Sagar
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
2152-2650 (2021)
DOI /
10.1016/j.clml.2020.08.008
Gold other
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic Analyses
Xu, Xu Steven; Moreau, Philippe; Usmani, Saad Z.; Lonial, Sagar; Jakubowiak, Andrzej; Oriol, Albert; Krishnan, Amrita; Blade, Joan; Luo, Man; Sun, Yu-Nien; Zhou, Honghui; Nnane, Ivo; Deraedt, William; Qi, Ming; Ukropec, Jon; Clemens, Pamela L.
ADVANCES IN THERAPY
0741-238X (2020)
DOI /
10.1007/s12325-020-01247-8
Green published, Gold other
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma
Jimenez, Cristina; Jara-Acevedo, Maria; Corchete, Luis A.; Castillo, David; Ordonez, Gonzalo R.; Sarasquete, Maria E.; Puig, Noemi; Martinez-Lopez, Joaquin; Prieto-Conde, Maria I.; Garcia-Alvarez, Maria; Chillon, Maria C.; Balanzategui, Ana; Alcoceba, Migu
JOURNAL OF MOLECULAR DIAGNOSTICS
1525-1578 (2017)
DOI /
10.1016/j.jmoldx.2016.08.004
Bronze
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Article
Response to First Cycle Is the Major Predictor of Long-Term Response to Lenalidomide and Dexamethasone Therapy in Relapsed and Refractory Multiple Myeloma: Can We Spare Patients the Toxicity and Costs of Additional Agents?
Gassiot, Susanna; Gonzalez, Yolanda; Morgades, Mireia; Motllo, Cristina; Clapes, Victoria; Maluquer, Clara; Ibarra, Gladys; Abril, Laura; Ribera, Josep-Maria; Oriol, Albert
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
2152-2650 (2019)
DOI /
10.1016/j.clml.2019.05.020
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Letter
Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma
Martinez-Lopez, J.; Sanchez-Vega, B.; Barrio, S.; Cuenca, I.; Ruiz-Heredia, Y.; Alonso, R.; Rapado, I.; Marin, C.; Cedena, M-T; Paiva, B.; Puig, N.; Mateos, M-V; Ayala, R.; Hernandez, M-T; Jimenez, C.; Rosinol, L.; Martinez, R.; Teruel, A-I; Gutierrez, N.;
LEUKEMIA
0887-6924 (2017)
DOI /
10.1038/leu.2017.58
Green published, Gold other
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Letter
Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup
Ludwig, Heinz; Dimopoulos, Meletios A.; Moreau, Philippe; Chng, Wee-Joo; Goldschmidt, Hartmut; Hajek, Roman; Facon, Thierry; Pour, Ludek; Niesvizky, Ruben; Oriol, Albert; Rosinol, Laura; Suvorov, Aleksandr; Gaidano, Gianluca; Pika, Tomas; Weisel, Katja; Go
LEUKEMIA & LYMPHOMA
1042-8194 (2017)
DOI /
10.1080/10428194.2017.1298755
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Review
The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma
Oriol, Albert; Abril, Laura; Torrent, Anna; Ibarra, Gladys; Ribera, Josep-Maria
THERAPEUTIC ADVANCES IN HEMATOLOGY
2040-6207 (2021)
DOI /
10.1177/20406207211019622
Gold, Green published
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed/refractory multiple myeloma
Jimenez-Segura, Raquel; Granell, Miquel; Gironella, Merce; Abella, Eugenia; Garcia-Guinon, Antoni; Oriol, Albert; Cabezudo, Elena; Clapes, Victoria; Alfons Soler, Joan; Escoda, Lourdes; Lopez-Pardo, Jordi; Fernandez de Larrea, Carlos; Teresa Cibeira, Maria
EUROPEAN JOURNAL OF HAEMATOLOGY
0902-4441 (2019)
DOI /
10.1111/ejh.13217
